SAVA
Filana Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.32
+2.33%Latest reported
- Last report date
- Mar 12, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.30
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +26.5%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Mar 12, 2026 | -$0.30 | -$0.26 | Beat 13.46% | — |
| Nov 12, 2025 | -$0.27 | -$0.22 | Beat 18.52% | — |
| Aug 14, 2025 | — | -$0.18 | — | — |
| May 8, 2025 | — | -$0.48 | — | — |
| Mar 3, 2025 | -$0.68 | -$0.57 | Beat 16.18% | — |
| Nov 7, 2024 | -$1.37 | -$0.58 | Beat 57.66% | — |
| May 10, 2024 | -$0.51 | -$1.41 | Miss -176.47% | — |
| Feb 28, 2024 | -$0.40 | -$0.50 | Miss -25.00% | $2.3M |
| Aug 3, 2023 | -$0.58 | -$0.63 | Miss -8.62% | — |
| May 1, 2023 | -$0.56 | -$0.58 | Miss -3.57% | — |
| Feb 28, 2023 | -$0.58 | -$0.47 | Beat 18.97% | -$1.8K |
| Aug 3, 2022 | -$0.42 | -$0.48 | Miss -14.29% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 6, 2026